Literature DB >> 35420893

Associated Costs Are a Barrier to HIV Preexposure Prophylaxis Access in the United States.

Karishma Srikanth1, Amy Killelea1, Andrew Strumpf1, Edwin Corbin-Gutierrez1, Tim Horn1, Kathleen A McManus1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35420893      PMCID： PMC9137017          DOI： 10.2105/AJPH.2022.306793

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   11.561


× No keyword cloud information.
  8 in total

1.  National Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2014 to 2018 : A Retrospective Cohort Study.

Authors:  Nathan W Furukawa; Weiming Zhu; Ya-Lin A Huang; Ram K Shrestha; Karen W Hoover
Journal:  Ann Intern Med       Date:  2020-09-08       Impact factor: 25.391

2.  Is Insurance a Barrier to HIV Preexposure Prophylaxis? Clarifying the Issue.

Authors:  Emma Sophia Kay; Rogério M Pinto
Journal:  Am J Public Health       Date:  2019-11-14       Impact factor: 9.308

3.  Estimated Lifetime HIV-Related Medical Costs in the United States.

Authors:  Adrienna Bingham; Ram K Shrestha; Nidhi Khurana; Evin U Jacobson; Paul G Farnham
Journal:  Sex Transm Dis       Date:  2021-04-01       Impact factor: 2.830

4.  Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.

Authors:  Rochelle P Walensky; Tim Horn; Nicole C McCann; Kenneth A Freedberg; A David Paltiel
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

5.  HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.

Authors:  A David Paltiel; Kenneth A Freedberg; Callie A Scott; Bruce R Schackman; Elena Losina; Bingxia Wang; George R Seage; Caroline E Sloan; Paul E Sax; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

6.  Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi.

Authors:  Trisha Arnold; Lauren Brinkley-Rubinstein; Philip A Chan; Amaya Perez-Brumer; Estefany S Bologna; Laura Beauchamps; Kendra Johnson; Leandro Mena; Amy Nunn
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

Review 7.  Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.

Authors:  Kenneth H Mayer; Allison Agwu; David Malebranche
Journal:  Adv Ther       Date:  2020-03-30       Impact factor: 3.845

8.  HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016.

Authors:  Ya-Lin A Huang; Weiming Zhu; Dawn K Smith; Norma Harris; Karen W Hoover
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-10-19       Impact factor: 17.586
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.